The present invention relates to compounds of structural formula I: I useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
本发明涉及结构式I的化合物:I可用作钾通道抑制剂,用于治疗心律失常等。
EP1667981A4
申请人:——
公开号:EP1667981A4
公开(公告)日:2008-08-13
ISOQUINOLINE POTASSIUM CHANNEL INHIBITORS
申请人:Merck & Co., Inc.
公开号:EP1667981A1
公开(公告)日:2006-06-14
US7763614B2
申请人:——
公开号:US7763614B2
公开(公告)日:2010-07-27
[EN] ISOQUINOLINE POTASSIUM CHANNEL INHIBITORS<br/>[FR] INHIBITEURS DE CANAL POTASSIQUE D'ISOQUINOLINE
申请人:MERCK & CO INC
公开号:WO2005030729A1
公开(公告)日:2005-04-07
The present invention relates to compounds of structural formula I: I useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.